Graybug Vision, Inc. (GRAY)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Frédéric Guerard
Employees:
30
275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY, CA 94065
650-487-2800

Graybug Vision, Inc. focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials. GB-401, an implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma.

Data derived from most recent annual or quarterly report
Market Cap 118.594 Million Shares Outstanding21.563 Million Avg 30-day Volume 27.797 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.46
Price to Revenue0.0 Debt to Equity0.0 EBITDA-35.37 Million
Price to Book Value0.5966 Operating Margin0.0 Enterprise Value-24.875 Million
Current Ratio16.534 EPS Growth0.678 Quick Ratio15.694
1 Yr BETA 2.427 52-week High/Low 22.12 / 5.0 Profit Margin0.0
Operating Cash Flow Growth1.759 Altman Z-Score1.6753 Free Cash Flow to Firm -26.763 Million

Are you looking for this stock instead?

View SEC Filings from GRAY instead.

View recent insider trading info

Graybug Vision, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding GRAY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GRAY

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-15 by BREUIL ROBERT S
  • 4: filed on 2023-03-06 by ZAMIRI PARISA
  • 4: filed on 2023-03-06 by GUERARD FREDERIC
  • 4: filed on 2023-03-06 by BREUIL ROBERT S
  • 4: filed on 2022-12-14 by BREUIL ROBERT S
  • 4: filed on 2022-12-01 by BREUIL ROBERT S
  • 4: filed on 2022-12-01 by ZAMIRI PARISA
  • 4: filed on 2022-12-01 by GUERARD FREDERIC
  • 4: filed on 2022-11-29 by BREUIL ROBERT S
  • 4: filed on 2022-11-29 by ZAMIRI PARISA

    • Events (8k)

  • 8-K: filed on 2023-03-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2023-03-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2023-02-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-28:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-11-22:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-22:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-23:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 2.06: Material Impairments
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    562.4 Thousand total shares from 4 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BREUIL ROBERT S CHIEF FINANCIAL OFFICER

    • Officer
    		 162,119 2023-03-14 11

    ZAMIRI PARISA CHIEF MEDICAL OFFICER

    • Officer
    		 135,338 2023-03-03 6

    GUERARD FREDERIC CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 383,682 2023-03-03 6

    SHAFFER CHRISTY L

    • Director
    		 40,000 2022-06-02 1

    BJERKHOLT ERIC

    • Director
    		 40,000 2022-06-02 1

    EASTLAND JULIA MARIE

    • Director
    		 40,000 2022-06-02 1

    ACKERMANN CHRISTINA

    • Director
    		 40,000 2022-06-02 1

    SAUER DIRK

    • Director
    		 40,000 2022-06-02 3

    CAGLE GERALD D.

    • Director
    		 12,500 2021-06-02 0

    SALAIN DANIEL CTOO

    • Officer
    		 0 2020-12-08 0

    FLYNN JAMES E

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
    		 6,704,119 2020-09-29 0

    CLARUS LIFESCIENCES III, L.P.

    CLARUS VENTURES III GP, L.P.

    BLACKSTONE CLARUS III L.L.C.

    BLACKSTONE HOLDINGS II L.P.

    BLACKSTONE HOLDINGS I/II GP L.L.C.

    BLACKSTONE GROUP INC

    BLACKSTONE GROUP MANAGEMENT L.L.C.

    SCHWARZMAN STEPHEN A

    • 10% Owner
    		 No longer subject to file 2020-09-29 0

    KEYOUNG HANSOO MICHAEL

    • Director
    		 1,133,596 2020-09-29 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP VI LLC

    • 10% Owner
    		 4,163,347 2020-09-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-15 16:15:09 -0400 2023-03-14 M 5,000 d 30,000 direct

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-15 16:15:09 -0400 2023-03-14 M 5,000 a 163,849 direct -11.2903 0.0 1 -11.2903 2

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-15 16:15:09 -0400 2023-03-14 F 1,730 $0.58 d 162,119 direct -11.2903 0.0 1 -11.2903 2

    GUERARD FREDERIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 19:02:23 -0500 2023-03-03 M 315,496 a 473,026 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    ZAMIRI PARISA - Officer CHIEF MEDICAL OFFICER

    		2023-03-06 19:04:47 -0500 2023-03-03 M 120,655 a 178,232 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    ZAMIRI PARISA - Officer CHIEF MEDICAL OFFICER

    		2023-03-06 19:04:47 -0500 2023-03-03 M 83,155 d 0 direct

    ZAMIRI PARISA - Officer CHIEF MEDICAL OFFICER

    		2023-03-06 19:04:47 -0500 2023-03-03 F 42,894 $0.57 d 135,338 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    ZAMIRI PARISA - Officer CHIEF MEDICAL OFFICER

    		2023-03-06 19:04:47 -0500 2023-03-03 M 28,125 d 393,750 direct

    ZAMIRI PARISA - Officer CHIEF MEDICAL OFFICER

    		2023-03-06 19:04:47 -0500 2023-03-03 M 9,375 d 84,375 direct

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 18:59:09 -0500 2023-03-03 M 9,937 d 89,438 direct

    GUERARD FREDERIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 19:02:23 -0500 2023-03-03 M 221,746 d 0 direct

    GUERARD FREDERIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 19:02:23 -0500 2023-03-03 F 89,344 $0.57 d 383,682 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    GUERARD FREDERIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 19:02:23 -0500 2023-03-03 M 65,625 d 918,750 direct

    GUERARD FREDERIC - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-06 19:02:23 -0500 2023-03-03 M 28,125 d 253,125 direct

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 18:59:09 -0500 2023-03-03 M 121,217 a 208,283 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 18:59:09 -0500 2023-03-03 M 83,155 d 0 direct

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 18:59:09 -0500 2023-03-03 F 49,434 $0.57 d 158,849 direct 1.7241 -15.5172 1.7241 2 -15.5172 6

    BREUIL ROBERT S - Officer CHIEF FINANCIAL OFFICER

    		2023-03-06 18:59:09 -0500 2023-03-03 M 28,125 d 393,750 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GRAYBUG VISION INC GRAY 2023-03-20 22:15:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 21:45:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 21:15:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 20:45:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 20:15:05 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 19:45:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 19:15:03 UTC -2.8981 7.4681 400000
    GRAYBUG VISION INC GRAY 2023-03-20 18:45:04 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 18:15:03 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 17:45:04 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 17:15:03 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 16:45:04 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 16:15:04 UTC 0.5927 3.9773 400000
    GRAYBUG VISION INC GRAY 2023-03-20 15:45:03 UTC 0.5927 3.9773 20000
    GRAYBUG VISION INC GRAY 2023-03-20 15:15:04 UTC 0.5927 3.9773 99
    GRAYBUG VISION INC GRAY 2023-03-20 14:45:04 UTC 0.0 0.0 100
    GRAYBUG VISION INC GRAY 2023-03-20 14:15:03 UTC 0.0 0.0 100
    GRAYBUG VISION INC GRAY 2023-03-20 13:45:03 UTC 0.0 0.0 100
    GRAYBUG VISION INC GRAY 2023-03-20 13:15:04 UTC 0.0 0.0 100
    GRAYBUG VISION INC GRAY 2023-03-17 22:15:03 UTC 0.465 4.105 600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments